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Abstract:
Background: Vernal keratoconjunctivitis is a bilateral and chronic
inflammation of the eye that can lead to severe ocular complications and
irnpaired quality of life in the person. Ambernassara is a mildew smoke that
has different rnedical properlies. The purpose of this study is to evaluate the
effect of ambernassara on allergic conjunctivitis disease.
Methods: This study is a double blind clinical trial. The statistical population
is all patients who referred to the Ophthalmology Center of Shafa Hospital
in Kerman with the findings of allergic conjunctivitis. The sample w-as
selected through available sampling method and 66 subjects were included
in the study. Patients were randomly divided into case and control groups. In
the case group, the patient was given an ambernassara, and explained that
they should be exposed to the smoke of the drug for a period of 10 minutes
u,hile the dry substance was placed in the spray dish. Then, for a period of
Keep the eyelids closed and rest for a few minutes. In the control group. a
drop of fluorometolone is used every 12 hours to use a drop in both e),es.
Two drops of optocrorle drops were used to prevent recurrence in both eves.
Ophthalmologist's findings and symptoms, and before and after treatmenl.
\\'ere completed by the ophthahnologist at the end of the second week an;
the end of the llrst month. All patients were advised to avoid direct sunlig;-..
and l-reat during this period. ln this study, the response to treatment of patie::s
ri'as divided into four groups: no response to treatment, a good response r -'.
80%o leduction of symptorns), relative response (ie, 40o/o reduction :.
svrllptolxs), and appropriate response (ie, response between a good 
"--:
adequate state ) defined. Of the 66 patients enrolled in the study, 34 patie:..
received ambernassara,12.5o/o had no response to treatment, and 4.99,0 h:: :
good response to treatment, and 53.1% had an appropriate response and l: :
.t
had appropriate responses to treatment.32 Patients received the usual
treatment, 29% had no response to treatment,5.9o/o had a good response to
treatrnent, and 70.60/o had an appropriate response and 20.6% responded
appropliately to treatment.
Results: In general, most patients had a relative response to treatment
(62.10/o), and only 5 (7 .6%) had no response to treatment. Compared to t1-re
usual treatment group and the group treated with ambernassara, in boti
groups, in the majority of cases, there was a relative response to treatment.
but there was no statistically significant difference between the two groups
(p:372.3), meaning that Ambernassara It can be as effective as treatmen:
fol allergic conjunctivitis.
Conclusion: ambernassara has been effective in treating patients u,i:.
allergic conjunctivitis as common as usual.
Kel,words: Allergic conjunctivitis, ambernassara, response to treatnte:-,.
properlies
